1. P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REPORTED SYMPTOMS IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN REAL-LIFE PRACTICE. (23rd June 2022) Authors: Efficace, F.; Cottone, F.; Yanez, B.; Castagnetti, F.; Caocci, G.; Bonifacio, M.; Patriarca, A.; Capodanno, I.; Miggiano, M. C.; Tiribelli, M.; Breccia, M.; Luciano, L.; Giai, V.; Iurlo, A.; Abruzzese, E.; Fava, C.; Rosti, G.; Cortes, J.; Kota, V.; Vignetti, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P712: ASCIMINIB ITALIAN MANAGED ACCESS PROGRAM: EFFICACY PROFILE IN HEAVILY PRE-TREATED CML PATIENTS. (23rd June 2022) Authors: Breccia, M.; Russo Rossi, A. V.; Martino, B.; Abruzzese, E.; Annunziata, M.; Binotto, G.; Ermacora, A.; Fava, C.; Giaccone, L.; Giai, V.; Nardozza, A. P.; Coco, P.; Gozzini, A.; Levato, L.; Lucchesi, A.; Luciano, L.; Maria Cristina, M.; Rege-Cambrin, G.; Santoro, M.; Scappini, B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: A MULTI-CENTER EXPERIENCE OF HYPOCELLULAR MYELODYSPLASTIC SYNDROMES (H-MDS): FROM CLINICAL DESCRIPTION TO IMMUNOLOGICAL CHARACTERIZATION. (September 2021) Authors: Calabretto, G.; Attardi, E.; Teramo, A.; Trimarco, V.; Barilà, G.; Vicenzetto, C.; Gasparini, V.; Massarotti, L.; Niscola, P.; Giai, V.; Poloni, A.; Finelli, C.; Mossuto, S.; Facco, M.; Vianello, F.; Semenzato, G.; Santini, V.; Zambello, R. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗